NetworkNewsBreaks

TuesdayApr 20, 2021 10:29 am

NetworkNewsBreaks – Sanwire Corp. (SNWR) Issues Shareholder Update

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, together with its 100% wholly owned subsidiary, Intercept Music Inc., today provided a shareholder update. Per the update, Sanwire has reached an agreement with a major shareholder/company officer to retire 100 million common shares, effective immediately. The retirement of shares coupled with the cancellation of over $1,000,000 of debt, including the cancellation of over $400,000 of convertible notes and interest in 2020, has greatly improved Sanwire's balance sheet and enhanced its ability to attract senior institutional investors. Among the highlights from fiscal 2020 at Intercept,…

Continue Reading

TuesdayApr 20, 2021 10:02 am

NetworkNewsBreaks – DGTL Holdings Inc.’s (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L) Hashoff to Launch New Campaign for Multinational Research Organization

DGTL Holdings (TSXV: DGTL) (OTCQB: DGTHF) (FSE: A2QB0L), an innovative company focused on the acquisition and acceleration of transformative digital media, marketing and advertising software technologies, today announced the securing of a new contract through its wholly owned subsidiary, Hashoff LLC. According to the update, the contract is with a NASDAQ-listed multinational research organization that specializes in helping companies with late-stage clinical trials. Based on the success of a similar campaign for a separate client in the category, the new global health care advocacy campaign will focus on supporting front-line workers and building social web community among health care professionals…

Continue Reading

TuesdayApr 20, 2021 9:51 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Appointment of New Global Positions

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has appointed two new positions at XP Diagnostics GmbH, its wholly owned German subsidiary. Wolfgang Probst will serve as the company’s new chief operations officer and Manfred Buchberger will be the new head of corporate development. An experienced management and finance consultant with impressive exposure to mergers and acquisitions, corporate re-organizations, and divestitures, Probst has a proven track record of leadership, strategic planning and organizational restructuring. In his new position, he will be responsible for managing the company's…

Continue Reading

TuesdayApr 20, 2021 9:35 am

NetworkNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) to Host Virtual 2021 Investor Day

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services, today announced plans to host its virtual 2021 Investor Day. The event is scheduled to take place from 1:00pm-3:00 p.m. ET on Thursday, April 29, 2021. As detailed in the update, members of the Nextech leadership team will provide an update on the company’s strategy, outlook and operations to investors and analysts. Nextech will publish details for the event next week on its website, where the company will also provide a copy of the virtual presentation to accommodate a…

Continue Reading

TuesdayApr 20, 2021 9:33 am

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Collects 2b Disease Trial Data; Receives NASDAQ Notice Regarding Annual Report

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, has announced collection of all patient data for its phase 2b Dupuytren’s disease trial, which was sponsored by the University of Oxford. The double-blind placebo-controlled trial involved 181 patients who were randomized across three sites, two in the United Kingdom and one in the Netherlands. While follow-up on the trial has been delayed by the COVID-19 pandemic, the company is now analyzing the information and has plans to announce top-line data in an upcoming…

Continue Reading

TuesdayApr 20, 2021 9:17 am

NetworkNewsBreaks – Infobird Co. Ltd (NASDAQ: IFBD) Announces Initial Public Offering Pricing

Infobird Co. (NASDAQ: IFBD), a software-as-a-service provider of innovative artificial intelligence (“AI”) powered, or enabled, customer engagement solutions in China, is sharing information about its previously announced initial public offering, which is expected to close on April 22, 2021. The company announced pricing for the offering, which is comprised of 6,250,000 ordinary shares; the shares will be available at $4 per share, before underwriting discounts and commissions. The announcement noted that the shares are being offered by Infobird on a firm commitment basis, and the company anticipates the public offering to total and estimated $25 million before payment of typical…

Continue Reading

MondayApr 19, 2021 3:15 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q4 and FY 2020 Financial Results, Provide Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced that it will host a teleconference to discuss its fourth quarter and fiscal year 2020 financial results and to provide a business update. The teleconference is scheduled to begin starting at 4:30 p.m. Eastern Time on Wednesday, April 21, 2021. Interested parties may join the live by dialing (877) 407-8033 (North America) or (201) 689-8033 (International) and stating verbal passcode: PBI FY and Q4 2020 Financial Call and Business Update. For those…

Continue Reading

MondayApr 19, 2021 3:06 pm

NetworkNewsBreaks – GT Biopharma (NASDAQ: GTBP) Releases Q4, Year-End Results, Company Update

GT Biopharma (NASDAQ: GTBP), a clinical-stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (“NK”) cell engager, TriKE(TM) protein biologic technology platform, has released fourth-quarter and year-end financial and company results for the period ended Dec. 31, 2020. Company highlights noted in the announcement included entering into a GMP manufacturing partnership with Cytovance; the initiation of manufacturing of additional solid tumor TriKE for lung, breast, ovarian and gastrointestinal cancer programs in preparation for FDA clinical trials; and enhancing and expanding the company’s board of directors. In addition, the company completed a successful listing on NASDAQ…

Continue Reading

MondayApr 19, 2021 2:49 pm

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Present at Virtual Planet MicroCap Showcase

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the upcoming Planet MicroCap Showcase. Scheduled to take place on April 20–22, 2021, the virtual Planet MicroCap event will feature 66 small-cap, micro-cap and nano-cap public and private companies; each company will present to the global investor audience via a virtual webcast. Trxade Group is slated to present Wednesday, April 21, at 12:30 p.m. The three-day event will feature workshops, keynote addresses and other presentations from well-known…

Continue Reading

MondayApr 19, 2021 2:48 pm

NetworkNewsBreaks – WAX Announces Debut Collection Launch Featuring K-Pop Boy Band – A.C.E

Worldwide Asset eXchange(TM) (“WAX”), the “King of NFTs,” today announced that K-NFT is presenting a special collection of digital collectibles featuring A.C.E, the K-pop boy band with more than 5.5 million fans across multiple social networks. According to the update, the band kicked off 2021 in style with collaborations alongside Steve Aoki, Grey and Thutmose, and now emerges as the first K-pop act to tokenize collectibles on the blockchain. The first series of A.C.E collectibles will feature 106 unique pieces of digital trading cards in five “all-kill” rarities and images of members Jun, Donghun, Wow, Kim Byeongkwan and Chan from…

Continue Reading